These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19245436)

  • 1. Efficient inhibition of SDF-1alpha-mediated chemotaxis and HIV-1 infection by novel CXCR4 antagonists.
    Iwasaki Y; Akari H; Murakami T; Kumakura S; Dewan MZ; Yanaka M; Yamamoto N
    Cancer Sci; 2009 Apr; 100(4):778-81. PubMed ID: 19245436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity.
    Ichiyama K; Yokoyama-Kumakura S; Tanaka Y; Tanaka R; Hirose K; Bannai K; Edamatsu T; Yanaka M; Niitani Y; Miyano-Kurosaki N; Takaku H; Koyanagi Y; Yamamoto N
    Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4185-90. PubMed ID: 12642669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel CXCR4 antagonist KRH-3955 is an orally bioavailable and extremely potent inhibitor of human immunodeficiency virus type 1 infection: comparative studies with AMD3100.
    Murakami T; Kumakura S; Yamazaki T; Tanaka R; Hamatake M; Okuma K; Huang W; Toma J; Komano J; Yanaka M; Tanaka Y; Yamamoto N
    Antimicrob Agents Chemother; 2009 Jul; 53(7):2940-8. PubMed ID: 19451305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXC chemokine receptor 4 expression and stromal cell-derived factor-1alpha-induced chemotaxis in CD4+ T lymphocytes are regulated by interleukin-4 and interleukin-10.
    Jinquan T; Quan S; Jacobi HH; Madsen HO; Glue C; Skov PS; Malling HJ; Poulsen LK
    Immunology; 2000 Mar; 99(3):402-10. PubMed ID: 10712670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell-line-tropic human immunodeficiency virus type 1 that is made resistant to stromal cell-derived factor 1alpha contains mutations in the envelope gp120 but does not show a switch in coreceptor use.
    Schols D; Esté JA; Cabrera C; De Clercq E
    J Virol; 1998 May; 72(5):4032-7. PubMed ID: 9557691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4.
    Schols D; Struyf S; Van Damme J; Esté JA; Henson G; De Clercq E
    J Exp Med; 1997 Oct; 186(8):1383-8. PubMed ID: 9334378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unique ligand binding sites on CXCR4 probed by a chemical biology approach: implications for the design of selective human immunodeficiency virus type 1 inhibitors.
    Choi WT; Tian S; Dong CZ; Kumar S; Liu D; Madani N; An J; Sodroski JG; Huang Z
    J Virol; 2005 Dec; 79(24):15398-404. PubMed ID: 16306611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SDF-1alpha is a potent inducer of HIV-1-Specific CD8+ T-cell chemotaxis, but migration of CD8+ T cells is impaired at high viral loads.
    Meditz AL; Schlichtemeier R; Folkvord JM; Givens M; Lesh KC; Ray MG; McCarter MD; Connick E
    AIDS Res Hum Retroviruses; 2008 Jul; 24(7):977-85. PubMed ID: 18671480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1alpha.
    Proost P; Struyf S; Schols D; Durinx C; Wuyts A; Lenaerts JP; De Clercq E; De Meester I; Van Damme J
    FEBS Lett; 1998 Jul; 432(1-2):73-6. PubMed ID: 9710254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single oral administration of the novel CXCR4 antagonist, KRH-3955, induces an efficient and long-lasting increase of white blood cell count in normal macaques, and prevents CD4 depletion in SHIV-infected macaques: a preliminary study.
    Nakasone T; Kumakura S; Yamamoto M; Murakami T; Yamamoto N
    Med Microbiol Immunol; 2013 Apr; 202(2):175-82. PubMed ID: 22772800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4.
    Hatse S; Princen K; Bridger G; De Clercq E; Schols D
    FEBS Lett; 2002 Sep; 527(1-3):255-62. PubMed ID: 12220670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor.
    Hatse S; Princen K; De Clercq E; Rosenkilde MM; Schwartz TW; Hernandez-Abad PE; Skerlj RT; Bridger GJ; Schols D
    Biochem Pharmacol; 2005 Sep; 70(5):752-61. PubMed ID: 16011832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SHP2 and cbl participate in alpha-chemokine receptor CXCR4-mediated signaling pathways.
    Chernock RD; Cherla RP; Ganju RK
    Blood; 2001 Feb; 97(3):608-15. PubMed ID: 11157475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of tyrosine kinase activation blocks the down-regulation of CXC chemokine receptor 4 by HIV-1 gp120 in CD4+ T cells.
    Su SB; Gong W; Grimm M; Utsunomiya I; Sargeant R; Oppenheim JJ; Ming Wang J
    J Immunol; 1999 Jun; 162(12):7128-32. PubMed ID: 10358157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel CXCR4 Targeting Protein SDF-1/54 as an HIV-1 Entry Inhibitor.
    Tan S; Li W; Li Z; Li Y; Luo J; Yu L; Yang J; Qiu M; Cheng H; Xu W; Jiang S; Lu L; Liu S; Ma W
    Viruses; 2019 Sep; 11(9):. PubMed ID: 31540474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradoxical downregulation of CXC chemokine receptor 4 induced by polyphemusin II-derived antagonists.
    Masuda R; Oishi S; Tanahara N; Ohno H; Hirasawa A; Tsujimoto G; Yano Y; Matsuzaki K; Navenot JM; Peiper SC; Fujii N
    Bioconjug Chem; 2012 Jun; 23(6):1259-65. PubMed ID: 22486464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ampelopsin, a small molecule inhibitor of HIV-1 infection targeting HIV entry.
    Liu DY; Ye JT; Yang WH; Yan J; Zeng CH; Zeng S
    Biomed Environ Sci; 2004 Jun; 17(2):153-64. PubMed ID: 15386941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced inhibition of human immunodeficiency virus type 1 by Met-stromal-derived factor 1beta correlates with down-modulation of CXCR4.
    Yang OO; Swanberg SL; Lu Z; Dziejman M; McCoy J; Luster AD; Walker BD; Herrmann SH
    J Virol; 1999 Jun; 73(6):4582-9. PubMed ID: 10233917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of HIV infection by bicyclams, highly potent and specific CXCR4 antagonists.
    De Clercq E
    Mol Pharmacol; 2000 May; 57(5):833-9. PubMed ID: 10779364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation of the signalling and antiviral properties of SDF-1-derived small peptides.
    Heveker N; Montes M; Germeroth L; Amara A; Trautmann A; Alizon M; Schneider-Mergener J
    Curr Biol; 1998 Mar; 8(7):369-76. PubMed ID: 9545196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.